Top 10 Owners of AstraZeneca PLC
| Stockholder | Stake | Shares owned |
|---|---|---|
| Franklin Advisers, Inc. | 0.48% | 14,854,728 |
| CIBC Private Wealth Advisors, Inc… | 0.35% | 10,730,763 |
| Norges Bank Investment Management | 0.30% | 9,308,677 |
| Fisher Asset Management LLC | 0.29% | 8,942,921 |
Who are the AstraZeneca investors?
Investor enquiries
- Andy Barnett. Head of Investor Relations.
- Josie Afolabi. Oncology.
- Tom Waldron. Oncology.
- Christer Gruvris. BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income.
- Morgan Sanford.
- Philip Sparks.
- Lauren Swales.
- Rachel Korolyshun.
Is AstraZeneca buy or sell?
AstraZeneca has received a consensus rating of Buy. The company’s average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.
US$0.25
AstraZeneca plc Share Price (AZN) Ordinary US$0.25 | AZN.
Share Statistics
| Avg Vol (3 month) 3 | 6.68M |
|---|---|
| Avg Vol (10 day) 3 | 6.01M |
| Shares Outstanding 5 | 3.1B |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 3.09B |
Why has AstraZeneca stock dropped?
During five years of share price growth, AstraZeneca actually saw its EPS drop 24% per year. This was, in part, due to extraordinary items impacting earning in the last twelve months.
Is AstraZeneca a US stock?
In the US, AstraZeneca’s Ordinary Shares are traded in the form of American Depositary Shares (ADSs), evidenced by American Depositary Receipts (ADRs), which are traded on Nasdaq under ticker symbol AZN.
Price T Rowe Associates Inc is the largest individual Astrazeneca shareholder, owning 85.92M shares representing 5.55% of the company. Price T Rowe Associates Inc’s Astrazeneca shares are currently valued at $5.24B.
Did Pfizer buy AstraZeneca?
LONDON/NEW YORK (Reuters) – Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker.
What is the target price for AstraZeneca?
Stock Price Forecast
The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 71.83, with a high estimate of 102.19 and a low estimate of 57.23. The median estimate represents a +14.45% increase from the last price of 62.76.
Looking ahead, analysts expect an almost 200% uplift in the current year and nearly 16% in 2023. And the share price has risen to reflect all the progress.
Is AstraZeneca stopped in USA?
(Reuters) -A U.S. government decision to end production of AstraZeneca’s COVID-19 vaccine at Emergent BioSolutions Inc’s Baltimore manufacturing facility is not an indication of concerns about its safety or effectiveness and will not impact the output of doses, a White House official said on Monday.
Is AstraZeneca debt free?
Company is virtually debt free. Company has a healthy Interest coverage ratio of 88.41.
Does AstraZeneca make a profit?
AstraZeneca revenues soar with nearly $4bn in Covid-19 vaccine sales. The drugmaker, which is just beginning to profit from its Covid-19 vaccine, has recorded $37.4bn in revenue. AstraZeneca has recorded soaring revenues of $37.4bn as it begins to profit from its Covid-19 vaccine for the first time.
How many times a year does AstraZeneca pay dividends?
Dividend Summary
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 1.3.
Is AstraZeneca still being used in UK?
The COVID-19 Vaccine AstraZeneca authorised under Regulation 174 remains in use and its product information has been updated in line with the product information of the GB CMA .
How much is AstraZeneca debt?
AstraZeneca annual net long-term debt for 2020 was $1.359B, a 235.9% decline from 2019. AstraZeneca annual net long-term debt for 2019 was $-1B, a 163.65% decline from 2018.
Compare AZN With Other Stocks.
| AstraZeneca Annual Net Long-Term Debt (Millions of US $) | |
|---|---|
| 2018 | $1,571 |
| 2017 | $238 |
| 2016 | $2,491 |
| 2015 | $5,044 |
Is AstraZeneca a top company?
AstraZeneca (US$37.4BN +41%)
After acquiring Alexion, AstraZeneca rockets into eighth place in 2022. Headquartered in Cambridge, UK, AstraZeneca specialises in providing solutions for major disease areas, including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Why is AstraZeneca Stock good?
Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AZN, demonstrate its potential to outperform the market.
How long until AstraZeneca is effective?
For most people the AstraZeneca primary course is 2 doses, 4 to 12 weeks apart. Most people have their second dose 12 weeks after their first, but it can be less time in certain situations. You may not be fully protected against COVID-19 until 7 to 14 days after your second dose.
Is AstraZeneca still effective?
Effectiveness of the AstraZeneca COVID-19 vaccine against hospitalisation after 2 doses was 92% (95% CI: 75–97) for Delta variant cases, compared with 86% (95% CI: 53–96) for Alpha variant cases.